GS-5745 (andecaliximab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GS-5745 (andecaliximab), covering 2021-02-01 to 2021-02-01. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis [Phase 1]